A cardiac panel is a collection of blood and urine tests that evaluate the health of your heart. It can help your doctor determine your risk of heart disease and stroke.
Showing all 13 results
- Sorry, this product cannot be purchased.
-
1%
CARDIAC PROFILE – BASIC
Heart failure (HF) has been recognized as a common complication of diabetes, with a prevalence of up to 22% in individuals with diabetes and increasing incidence rates. Detection of people at high risk for HF (stage A) or those with stage B HF (without symptoms but with either structural/ functional cardiac abnormalities or elevated biomarkers natriuretic peptides or troponin) would permit earlier implementation of effective strategies to prevent or delay the progression to advanced HF in individuals with diabetes
₹3,050.00Original price was: ₹3,050.00.₹3,000.00Current price is: ₹3,000.00. -
3%
CARDIAC RISK MARKERS – ADVANCED
Indians are at very high risk of developing Atherosclerotic Cardiovascular disease (ASCVD), they usually get the disease at an early age, have a more severe form of the disease and have poorer outcome as compared to the western populations. This is due to high prevalence of Atherogenic dyslipidemia, central abdominal adiposity & increased transfats in our diet. Among the various risk factors for ASCVD such as dyslipidemia, Diabetes mellitus, sedentary lifestyle, Hypertension, smoking, genetic predisposition etc., dyslipidemia has the highest population attributable risk for MI. Hence monitoring lipid profile regularly for effective management of dyslipidemia remains one of the most important healthcare targets for prevention of ASCVD. This monitoring should start as early as 20 years of age. Lipid association of India (LAI 2020) has categorized individuals into Low risk, Moderate risk, High risk, Very high risk & Extreme risk on the basis of their LDL-C, Non-HDL-C & ApoB blood levels. Use of lipid lowering drugs particularly statins has reduced ASCVD morbidity and mortality; however significant residual risk for the events remains. Additional testing for inflammatory (HsCRP), non-lipid (Homocysteine) and other lipid biomarkers (Apo A, Apo B & Lp(a) ) may be considered for risk refinement. Presence of one or more secondary risk factor should prompt the clinician to consider drug therapy for patient whose atherogenic cholesterol level is higher than goal level.
₹1,550.00Original price was: ₹1,550.00.₹1,500.00Current price is: ₹1,500.00. -
6%
₹3,200.00Original price was: ₹3,200.00.₹3,000.00Current price is: ₹3,000.00. -
9%
HEART FAILURE SCREEN
Heart failure (HF) has been recognized as a common complication of diabetes, with a prevalence of up to 22% in individuals with diabetes and increasing incidence rates. Detection of people at high risk for HF (stage A) or those with stage B HF (without symptoms but with either structural/ functional cardiac abnormalities or elevated biomarkers natriuretic peptides or troponin) would permit earlier implementation of effective strategies to prevent or delay the progression to advanced HF in individuals with diabetes.
Heart failure screening involves tests to assess heart function and identify potential problems, including blood tests, ECGs, echocardiograms, and potentially imaging tests like chest X-rays or stress tests.
Here’s a more detailed explanation of heart failure screening:
1. Initial Evaluation and Tests:
History and Physical Examination:
Your doctor will start by asking about your symptoms, medical history, and family history of heart problems. They will also listen to your heart, check your heart rate, and blood pressure.
Electrocardiogram (ECG or EKG):
This test records the electrical activity of your heart, helping to detect irregular heart rhythms and other abnormalities.Blood Tests:
These tests can help identify underlying causes of heart failure and assess overall health.Blood tests for specific proteins made by the heart and blood vessels, like natriuretic peptides, can help diagnose and monitor heart failure.
Ventriculography:₹5,500.00Original price was: ₹5,500.00.₹5,000.00Current price is: ₹5,000.00. -
50%
HIGH SENSITIVITY TROPONIN I
Troponin-I is a cardiac marker elevated only in patients suffering from acute Myocardial Infarction. Patients with renal disease or acute muscle injury show normal levels. High sensitivity assays can detect elevated levels of Troponin-I (above the 99th percentile of an apparently healthy reference population) within 3 hours after the onset of chest pain.
₹1,000.00Original price was: ₹1,000.00.₹500.00Current price is: ₹500.00. -
14%
JAANCH HEALTHY HEART (ADVANCED)
Indians are at very high risk of developing Atherosclerotic Cardiovascular disease (ASCVD) and usually get the disease at an early age, have a more severe form of the disease and have poorer outcome as compared to the western populations.This is due to high prevalence of Atherogenic dyslipidemia, central abdominal adiposity & increased transfats in our diet. Among the various risk factors for ASCVD such as dyslipidemia, Diabetes mellitus, sedentary lifestyle, Hypertension, smoking, genetic predisposition etc., dyslipidemia has the highest population attributable risk for MI. Hence monitoring lipid profile regularly for effective management of dyslipidemia remains one of the most important healthcare targets for prevention of ASCVD. This monitoring should start as early as 20 years of age. This test panel helps clinician to decide if therapy is required and what should be the treatment goal for you.
₹3,500.00Original price was: ₹3,500.00.₹2,999.00Current price is: ₹2,999.00. -
16%
JAANCH HEALTHY HEART (ADVANCED)
Indians are at very high risk of developing Atherosclerotic Cardiovascular disease (ASCVD) and usually get the disease at an early age, have a more severe form of the disease and have poorer outcome as compared to the western populations.This is due to high prevalence of Atherogenic dyslipidemia, central abdominal adiposity & increased transfats in our diet. Among the various risk factors for ASCVD such as dyslipidemia, Diabetes mellitus, sedentary lifestyle, Hypertension, smoking, genetic predisposition etc., dyslipidemia has the highest population attributable risk for MI. Hence monitoring lipid profile regularly for effective management of dyslipidemia remains one of the most important healthcare targets for prevention of ASCVD. This monitoring should start as early as 20 years of age. This test panel helps clinician to decide if therapy is required and what should be the treatment goal for you.
₹2,999.00Original price was: ₹2,999.00.₹2,500.00Current price is: ₹2,500.00. -
6%
JAANCH HEALTHY HEART (BASIC)
Indians are at very high risk of developing Atherosclerotic Cardiovascular disease (ASCVD) and usually get the disease at an early age, have a more severe form of the disease and have poorer outcome as compared to the western populations.This is due to high prevalence of Atherogenic dyslipidemia, central abdominal adiposity & increased transfats in our diet. Among the various risk factors for ASCVD such as dyslipidemia, Diabetes mellitus, sedentary lifestyle, Hypertension, smoking, genetic predisposition etc., dyslipidemia has the highest population attributable risk for MI. Hence monitoring lipid profile regularly for effective management of dyslipidemia remains one of the most important healthcare targets for prevention of ASCVD. This monitoring should start as early as 20 years of age. This test panel helps clinician to decide if therapy is required and what should be the treatment goal for you
₹1,499.00Original price was: ₹1,499.00.₹1,400.00Current price is: ₹1,400.00. -
16%
JAANCH HEALTHY HEART (BASIC)
Indians are at very high risk of developing Atherosclerotic Cardiovascular disease (ASCVD) and usually get the disease at an early age, have a more severe form of the disease and have poorer outcome as compared to the western populations.This is due to high prevalence of Atherogenic dyslipidemia, central abdominal adiposity & increased transfats in our diet. Among the various risk factors for ASCVD such as dyslipidemia, Diabetes mellitus, sedentary lifestyle, Hypertension, smoking, genetic predisposition etc., dyslipidemia has the highest population attributable risk for MI. Hence monitoring lipid profile regularly for effective management of dyslipidemia remains one of the most important healthcare targets for prevention of ASCVD. This monitoring should start as early as 20 years of age. This test panel helps clinician to decide if therapy is required and what should be the treatment goal for you.
₹1,800.00Original price was: ₹1,800.00.₹1,499.00Current price is: ₹1,499.00. -
9%
LIPID PROFILE COMPLETE
Indians are at very high risk of developing Atherosclerotic Cardiovascular disease (ASCVD), they usually get the disease at an early age, have a more severe form of the disease and have poorer outcome as compared to the western populations. This is due to high prevalence of Atherogenic dyslipidemia, central abdominal adiposity & increased transfats in our diet. Among the various risk factors for ASCVD such as dyslipidemia, Diabetes mellitus, sedentary lifestyle, Hypertension, smoking, genetic predisposition etc., dyslipidemia has the highest population attributable risk for MI. Hence monitoring lipid profile regularly for effective management of dyslipidemia remains one of the most important healthcare targets for prevention of ASCVD. This monitoring should start as early as 20 years of age. Lipid association of India (LAI 2020) has categorized individuals into Low risk, Moderate risk, High risk, Very high risk & Extreme risk on the basis of their LDL-C, Non-HDL-C & ApoB blood levels. Use of lipid lowering drugs particularly statins has reduced ASCVD morbidity and mortality; however significant residual risk for the events remains. Additional testing for inflammatory (HsCRP), non-lipid (Homocysteine) and other lipid biomarkers (Apo A, Apo B & Lp(a) ) may be considered for risk refinement. Presence of one or more secondary risk factor should prompt the clinician to consider drug therapy for patient whose atherogenic cholesterol level is higher than goal level.
₹2,200.00Original price was: ₹2,200.00.₹2,000.00Current price is: ₹2,000.00. -
12%
LIPID PROFILE EXTENDED
Indians are at very high risk of developing Atherosclerotic Cardiovascular disease (ASCVD), they usually get the disease at an early age, have a more severe form of the disease and have poorer outcome as compared to the western populations. This is due to high prevalence of Atherogenic dyslipidemia, central abdominal adiposity & increased transfats in our diet. Among the various risk factors for ASCVD such as dyslipidemia, Diabetes mellitus, sedentary lifestyle, Hypertension, smoking, genetic predisposition etc., dyslipidemia has the highest population attributable risk for MI. Hence monitoring lipid profile regularly for effective management of dyslipidemia remains one of the most important healthcare targets for prevention of ASCVD. This monitoring should start as early as 20 years of age. Lipid association of India (LAI 2020) has categorized individuals into Low risk, Moderate risk, High risk, Very high risk & Extreme risk on the basis of their LDL-C, Non-HDL-C & ApoB blood levels. Use of lipid lowering drugs particularly statins has reduced ASCVD morbidity and mortality; however significant residual risk for the events remains. Additional testing for inflammatory (HsCRP), non-lipid (Homocysteine) and other lipid biomarkers (Apo A, Apo B & Lp(a) ) may be considered for risk refinement. Presence of one or more secondary risk factor should prompt the clinician to consider drug therapy for patient whose atherogenic cholesterol level is higher than goal level.
₹1,600.00Original price was: ₹1,600.00.₹1,400.00Current price is: ₹1,400.00. -
10%
NT-PROBNP(NT-PRO BNP (N-TERMINAL PRO B TYPE NATRIURETIC PEPTIDE))
N-terminal precursor of brain natriuretic peptide (NT-proBNP) are released from myocardial cells in response to volume expansion and increased wall tension. They are well established rule-out tools for cardiac disease in unselected communities. NT-proBNP value <125 pg/mL excludes cardiac dysfunction with a high level of certainty in patients presenting with dyspnea. As the value increases heart failure becomes more likely. NT-proBNP levels are correlated with New York Heart Association (NYHA) functional classes for CHF. However, the role of natriuretic peptides extends beyond heart failure diagnosis; it is a clinical support tool in risk stratification & management in both inpatient and outpatient settings. Recent studies have shown that it can also be used for Cardiovascular risk assessment in asymptomatic patients with Type 2 Diabetes Mellitus.
₹2,000.00Original price was: ₹2,000.00.₹1,800.00Current price is: ₹1,800.00. -
18%
OBESITY PANEL
Leptin is an adipocyte derived hormone that is essential for normal body weight regulation. Leptin production is under neuroendocrine control and the serum concentrations vary directly with the amount of triglycerides stored in adipose tissue depots.
₹5,500.00Original price was: ₹5,500.00.₹4,500.00Current price is: ₹4,500.00.
